NeuroPace, Inc.
NASDAQNPCE reports today with the Street broadly constructive but key questions about profitability still unanswered. Options positioning has tilted more defensive in the run-up to the print. The put/call ratio climbed to 0.78, well above its 20-day average of 0.54 — about 1.2 standard deviations elevated — suggesting investors have been adding more downside protection than usual heading…
NPCE short interest falls 23% in one week to 2.14% of float, lowest level since early April. Cost to borrow plummets 61% to 0.58%, signaling reduced short pressure. Stock trades near $16 with next earnings June 5.
Snapshot as of 20 Sept 2026
NPCE reports today with the Street broadly constructive but key questions about profitability still unanswered. Options positioning has tilted more defensive in the run-up to the print. The put/call ratio climbed to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NPCE — free to start on ORTEX.
Sign up for free →Open NPCE on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live NPCE data →